Accelerate Diagnostics, Inc. announced that Nedal Safwat has been appointed Chief Strategy Officer. Dr. Safwat joins Accelerate from BioMerieux, the world's leading microbiology diagnostics company. Dr. Safwat brings significant experience in the microbiology diagnostics and life sciences industries. During his 11 years at BioMerieux, he held a variety of roles of increasing importance, including positions in sales, product management, global marketing, and, most recently, leading the ID/AST Franchise. Prior to joining BioMerieux, Dr. Safwat held positions at Luminex Corporation, Strategic Diagnostics Incorporated, Miltenyi Biotec Incorporated, and Bayer Diagnostics.